0910-AF26 200510 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative--Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; and Technical Amendment Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 606 21 CFR 610 21 CFR 640 21 USC 321 21 USC 360j 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 371 21 USC 374 42 USC 216 42 USC 262 42 USC 263 42 USC 263a 42 USC 264 42 USC 300aa to 25 21 USC 331 21 USC 310 No NPRM 07/30/2003 68 FR 44678 NPRM Comment Period End 10/28/2003 Final Action 06/00/2006 No No None No NA Not Collected 0910-AB26 Split from Brenda Friend 0910 Food and Drug Administration FDA 301 827-6210 Center for Biologics Evaluation and Research, 1401 Rockville Pike, Suite 200N (HFM-17), Rockville MD 20852-1448